Scholar Rock submitted its BLA of apitegromab for the treatment of patients with Spinal Muscular Atrophy with a request for ...

Group sales grew by 7%1 at constant exchange rates (CER; 3% in CHF), driven by strong demand for both medicines and diagnostics.Excluding COVID-19, Group sales increased by 9%.

BURLINGTON, Mass. - Azenta, Inc. (NASDAQ: AZTA), a global provider of life sciences solutions, announced the election of ...

PepGen Inc. (PEPG) shares tumbled to a 52-week low this week, with the stock price touching down at $1.76. According to InvestingPro data, the company maintains a strong liquidity position with a ...

Panelists discuss how modern FDA-approved intravenous iron formulations, including ferric carboxymaltose, ferumoxytol, and ...

The U.S. Food and Drug Administration (FDA) recently issued two new guidance documents governing details of the Accelerated Approval ...

The Muscular Dystrophy Association (MDA) is honoring a longtime researcher and an LGMD patient advocate with its 2025 Legacy ...

Whether New Hampshire patients nearing death should be able end their own life with the help of a physician was up for debate ...

The firm will share new overall survival data from the INAVO120 trial with regulators to support the breast cancer drug's approval.